Table 2. Scenarios and predicted elimination dates.
| Country | Minimum elimination
scenario and interventions |
MDA | LLIN | Elimination date
(predicted range) |
National
elimination goal |
|---|---|---|---|---|---|
| Afghanistan | Effective usage | Yes | Yes | 2025 (2025,2027) | None |
| Bangladesh | Effective usage | No | No | 2025 (2024,2029) | 2035 |
| Bhutan | Effective usage | No | No | 2024 (2023, 2025) | 2018 |
| Cambodia | New LLINs | Yes | No | 2023 (2022, 2030) | 2025 |
| China | Business as usual (already
eliminated by 2017) |
No | No | 2017 | 2020 |
| DPRK | New P. vivax drug | No | Yes | 2028 (2027, 2030) | 2025 |
| India | New LLINs | No | Yes | 2028 (2026, 2030) | 2030 |
| Indonesia | Effective usage | Yes | No | 2025 (2022,2028) | None |
| Lao PDR | New P. falciparum drug | Yes | Yes | 2025 (2022,>2030) | |
| Malaysia | IRS | No | No
No |
2023 (2019, 2029) | 2020 |
| Myanmar | New P. falciparum drug | Yes | Yes | 2025 (2024,>2030) | None |
| Nepal | Effective usage | No | No | 2022 (2017, 2026) | 2026 |
| Pakistan | Effective usage | Yes | Yes | 2022 (2021, 2030) | None |
| PNG | Effective usage | Yes | No | 2025 (2025,2028) | |
| Philippines | Effective usage | No | No | 2021 (2017,2023) | 2030 |
| ROK | Business as usual | No | No | 2017 (2017,2019) | 2017 |
| Solomon Islands | New LLINs | Yes | No | 2028(2026, 2029) | |
| Sri Lanka | Business as usual (already
eliminated by 2017) |
No | No | Already eliminated
in 2013 |
2012 |
| Thailand | New P. vivax drug | No | No | 2026 (2025, 2029) | 2024 |
| Timor-Leste | Universal coverage | No | No | 2019 (2017,2024) | |
| Vanuatu | Effective usage | Yes | No | 2021 (2021, 2024) | 2025 |
| Viet Nam | Effective usage | No | No | 2024 (2022, 2027) | 2030 |